AzTrials
AzTrials

StammeringNCT00945113

Pilot: Group Therapy for Children Who Stammer

A study testing One-week speech therapy group in people with Stammering, run by Newcastle-upon-Tyne Hospitals NHS Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to answer the question: Is a large-scale research study of the effectiveness of group speech and language therapy (SALT) for young people who stammer possible? The study will look at the issues involved in setting up a large-scale investigation of treatment for young people who stammer. Read more about this study

Who is it for?
Ages 8 to 15 years
Conditions the study is for
Stammering
What is being tested?
One-week speech therapy group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteUnited Kingdom
Study dates
Jun 2009to Oct 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Aged between 8;0 years and 15;11 years at 20.07.09
  • Currently in treatment, on review or on waiting list for treatment.
  • Has had an initial NHS Speech and Language Therapy assessment by Newcastle, Northumberland or North Tyneside Speech and Language Therapy service.
  • Has a diagnosis of stammering.
  • Has sufficient understanding of spoken (English) language to score at or above the 16th percentile on the Understanding Linguistic Concepts subtest of the CELF-4UK assessment.
  • Available to attend treatment for the whole week of 20th July 2009
  • Available to attend treatment for the whole week of 24th August 2009

Who cannot join

  • Diagnosis of Attention and/or Hyperactivity Disorders
  • Diagnosis of moderate or severe general learning difficulties
  • Diagnosis of moderate or severe receptive and/or pragmatic language difficulties
  • Parent/carer for whom an interpreter would be required

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Newcastle-upon-Tyne Hospitals NHS Trust

    Newcastle upon Tyne, Tyne and Wear

Other trials in United Kingdom

About this study

Official title: A Pilot Randomised Controlled Trial of the Effectiveness of Intensive Group Speech and Language Therapy as a Treatment for Older Children Who Stammer

The aim of the study is to answer the question: Is a large-scale research study of the effectiveness of group speech and language therapy (SALT) for young people who stammer possible?

The study will look at the issues involved in setting up a large-scale investigation of treatment for young people who stammer. It will inform the investigators whether larger studies would be possible and give some early-stage information on the effectiveness of group SALT for these young people. The findings will pave the way for building and testing out treatment programmes where there will be clear positive benefit for young people who stammer and their families.

Read more

To answer the research question, the study will tell the investigators (a) how easy/difficult it was to get people to take part, (b) young people and parents'/carers' views on taking part and (c) whether the assessments were able to pick up changes in speech and attitudes towards stammering reported by the young people and their carers.

Sufficient numbers of participants were not recruited to carry out the intended rehearsal pilot RCT study design.

Conditions
Stammering
Being tested
One-week speech therapy group
Keywords
pilot, stammer, stutter, children, randomised controlled trial, RCT, Speech and Language Therapy, Stuttering
Medical subject headings
Stuttering, Communication Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • One-week speech therapy groupBehavioural

    One-week cross-district speech therapy group for older children (aged 8 to 15) who stammer

Study groups in NCT00945113
Study groupRoleWhat they receive
Treatment groupExperimentalattendance at one-week speech therapy group
Receives: Behavioral: One-week speech therapy group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall Assessment of the Speaker's Evaluation of Stuttering (OASES) score

    Measured: July 2009 week 2, July 2009 week 4, October 2009 week 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2009 (estimated)
  2. Study startJun 2009
  3. Primary completionOct 2009
  4. Study completionOct 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00945113
Sponsor's protocol ID
4565
Status last verified
Oct 2015
First submitted
21 Jul 2009
Last updated
12 Oct 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing One-week speech therapy group in people with Stammering, run by Newcastle-upon-Tyne Hospitals NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall Assessment of the Speaker's Evaluation of Stuttering (OASES) score (time frame: July 2009 week 2, July 2009 week 4, October 2009 week 4). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2015; AzTrials last refreshed its copy on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in